ZFIN Person: Breuer, Maximilian

ZFIN ID: ZDB-PERS-170807-1

ZFIN ID: ZDB-PERS-170807-1

Breuer, Maximilian

Email:	Maximilian.Breuer@ruhr-uni-bochum.de
URL:
Affiliation:
Address:	INRS- Institut Armand-Frappier 531 Boul des Prairies H7V 1B7 Laval, QC
Country:	Canada
Phone:	+1 438 341-0445
Fax:
ORCID ID:	0000-0002-8830-3684

BIOGRAPHY AND RESEARCH INTERESTS

PUBLICATIONS

Vedder, V.L., Reinberger, T., Haider, S.M.I., Eichelmann, L., Odenthal, N., Abdelilah-Seyfried, S., Aherrahrou, Z., Breuer, M., Erdmann, J. (2023) pyHeart4Fish: Chamber-specific heart phenotype quantification of zebrafish in high-content screens. Frontiers in cell and developmental biology. 11:11438521143852

Jamadagni, P., Breuer, M., Schmeisser, K., Cardinal, T., Kassa, B., Parker, J.A., Pilon, N., Samarut, E., Patten, S.A. (2021) Chromatin remodeller CHD7 is required for GABAergic neuron development by promoting PAQR3 expression. EMBO reports. 22(6):e50958

Breuer, M., Patten, S.A. (2020) A Great Catch for Investigating Inborn Errors of Metabolism-Insights Obtained from Zebrafish. Biomolecules. 10(9):

Breuer, M., Guglielmi, L., Zielonka, M., Hemberger, V., Kölker, S., Okun, J.G., Hoffmann, G.F., Carl, M., Sauer, S.W., Opladen, T. (2019) QDPR homologues in Danio rerio regulate melanin synthesis, early gliogenesis, and glutamine homeostasis. PLoS One. 14:e0215162

Zielonka, M., Breuer, M., Okun, J.G., Carl, M., Hoffmann, G.F., Kölker, S. (2018) Pharmacologic rescue of hyperammonemia-induced toxicity in zebrafish by inhibition of ornithine aminotransferase. PLoS One. 13:e0203707

Dimitrov, B., Himmelreich, N., Hipgrave Ederveen, AL., Lüchtenborg, C., Okun, J.G., Breuer, M., Hutter, A.M., Carl, M., Guglielmi, L., Hellwig, A., Thiemann, K.C., Jost, M., Peters, V., Staufner, C., Hoffmann, G.F., Hackenberg, A., Paramasivam, N., Wiemann, S., Eils, R., Schlesner, M., Strahl, S., Brügger, B., Wuhrer, M., Christoph Korenke, G., and Thiel, C. (2018) Cutis laxa, exocrine pancreatic insufficiency and altered cellular metabolism as additional symptoms in a new patient with ATP6AP1-CDG. Molecular genetics and metabolism. 123(3):364-374

Kopajtich, R., Murayama, K., Janecke, A.R., Haack, T.B., Breuer, M., Knisely, A.S., Harting, I., Ohashi, T., Okazaki, Y., Watanabe, D., Tokuzawa, Y., Kotzaeridou, U., Kölker, S., Sauer, S., Carl, M., Straub, S., Entenmann, A., Gizewski, E., Feichtinger, R.G., Mayr, J.A., Lackner, K., Strom, T.M., Meitinger, T., Müller, T., Ohtake, A., Hoffmann, G.F., Prokisch, H., Staufner, C. (2016) Biallelic IARS Mutations Cause Growth Retardation with Prenatal Onset, Intellectual Disability, Muscular Hypotonia, and Infantile Hepatopathy. American journal of human genetics. 99(2):414-22

NON-ZEBRAFISH PUBLICATIONS
Himmelreich N, Dimitrov B, Geiger V, Zielonka M, Hutter AM, Beedgen L, Hüllen A, Breuer M, Peters V, Thiemann KC, Hoffmann GF, Sinning I, Dupré T, Vuillaumier-Barrot S, Barrey C, Denecke J, Kölfen W, Düker G, Ganschow R, Lentze MJ, Moore S, Seta N, Ziegler A, Thiel C. Novel variants and clinical symptoms in four new ALG3‐CDG patients, review of the literature, and identification of AAGRP‐ALG3 as a novel ALG3 variant with alanine and glycine‐rich N‐terminus (2019). Human Mutation. 1– 14. https://doi.org/10.1002/humu.23764